Zeeuws Investment Fund
  • ABOUT US
    • ZIF
    • FUND MANAGER
  • CRITERIA
  • INVESTMENTS
    • TOXYS
    • DOVIDEQ MEDICAL
    • INNO4LIFE
    • MAGNETIC
    • MIMETAS
    • EAGLET EYE
    • SOTERIA MEDICAL
    • ILLUXTRON
  • NEWS
  • CAREERS
  • CONTACT
  • DUTCH

PAUL VULTO OF MIMETAS HAS BEEN INTERVIEWED ABOUT A NEW FUND

9/28/2017

 
The Dutch government and the European Investment Bank have set up a new fund to help fast-growing young companies fulfill their enormous potential and provide them with the necessary capital.
​Paul Vulto of Mimetas, which develops methods for testing medicine in microscopic human tissues in microfluidic chips, has been interviewed as Mimetas is a good example of such a company.


You can see the interview below and/or read the full article (in Dutch) here. 


More information about Mimetas.

INNO4LIFE RECEIVES FUNDING FOR SERIALIZATION IN PHARMACY AND INTERNATIONAL GROWTH.

9/4/2017

 
Picture
Inno4Life, machine building company in the life science industries, will receive an investment from the Brabant Development Agency (BOM), Holland Venture, TIIN Capital and ZIF. Inno4Life uses the investment for the development of serialization equipment solutions in packaging machines for medicines and to accelerate the international growth of the company.
 
Inno4Life provides integrated tailor-made solutions and machines that meet the ever changing needs within the Life Sciences sector, especially in the pharmaceutical and biotech industries. The machines and automation solutions from Inno4Life include packaging processes for track & tracing of medicines. Inno4Life develops and builds machines for the top ten pharmaceutical companies worldwide. The organization offers solutions to companies in various areas e.g. automated filling systems, loading systems and fits robot and vision technology. 
 
The pharmaceutical industry is continuously changing as a result of mergers or reorganizations. The level of automation intensifies, prices are under pressure and legislation is getting stricter. Johan Klootwijk, CEO Inno4Life: "Innovations in production processes are necessary for pharmaceutical companies. Companies have to comply with increasingly strict legislation and at the same time produce more efficiently and more effectively than competitors. Partly because of these developments, it is essential that specialist suppliers innovate continuously."
 
Innovation by new legislation
In 2019 all packages of prescription medicines need to be provided with a unique code. Pharmaceutical manufacturers print these unique codes on the packaging. Pharmacists scan this unique code to determine the authenticity of the medicine before they give it to patients. Inno4Life provides expertise and solutions for pharmaceutical companies to meet this new legislation. 
"Our ambition is to increase our reputation as an international supplier of automated production equipment," continues Klootwijk. "By leading the way in providing customer specific, innovative solutions with exceptional customer service, we offer our customers the best possible service. With the knowledge and the capital of these investors we can pursue our international growth ambitions. "


More information about Inno4Life

    ARCHIVES

    March 2020
    April 2018
    November 2017
    September 2017
    May 2017
    January 2017
    September 2016
    March 2016
    February 2016
    December 2015
    November 2015
    September 2015
    July 2015
    June 2015
    February 2014
    January 2014
    January 2013

    CATEGORIES

    All
    DOVIDEQ Medical
    Eaglet Eye
    Illuxtron
    Inno4Life
    MAGnetIC
    MIMETAS
    Soteria Medical BV
    Toxys

ZEEUWS INVESTMENT FUND
Edisonweg 41a | 4382 NV | Vlissingen | The Netherlands | + 31 (0)6 24810367 | johan@zeeuwsinvesteringsfonds.nl | Privacy policy